131 related articles for article (PubMed ID: 36917191)
1. Residence in Peripheral Regions and Low Socioeconomic Status Are Associated With Worse Outcomes of Inflammatory Bowel Diseases: A Nationwide Study From the epi-IIRN.
Ledder O; Harel S; Lujan R; Friss C; Orlanski-Meyer E; Yogev D; Loewenberg Weisband Y; Greenfeld S; Kariv R; Lederman N; Matz E; Schwartz D; Focht G; Dotan I; Turner D
Inflamm Bowel Dis; 2024 Jan; 30(1):1-8. PubMed ID: 36917191
[TBL] [Abstract][Full Text] [Related]
2. Incidence, Management, and Outcomes of Very Early Onset Inflammatory Bowel Diseases and Infantile-Onset Disease: An Epi-IIRN Study.
Atia O; Benchimol EI; Ledderman N; Greenfeld S; Kariv R; Weisband YL; Matz E; Ollech J; Dotan I; Assa A; Shouval DS; Uhlig HH; Muise AM; Olén O; Kuenzig ME; Kaplan GG; Turner D
Clin Gastroenterol Hepatol; 2023 Sep; 21(10):2639-2648.e6. PubMed ID: 36336312
[TBL] [Abstract][Full Text] [Related]
3. Early Initiation of Biologics and Disease Outcomes in Adults and Children With Inflammatory Bowel Diseases: Results From the Epidemiology Group of the Nationwide Israeli Inflammatory Bowel Disease Research Nucleus Cohort.
Lujan R; Buchuk R; Focht G; Yogev D; Greenfeld S; Ben-Tov A; Weisband YL; Lederman N; Matz E; Ben Horin S; Dotan I; Nevo D; Turner D
Gastroenterology; 2024 May; 166(5):815-825.e22. PubMed ID: 38331205
[TBL] [Abstract][Full Text] [Related]
4. Pre- and Perinatal Factors Predicting Inflammatory Bowel Disease: A Population-Based Study with Fifty Years of Follow-Up.
Velosa M; Hochner H; Yerushalmi B; Harel S; Friss C; Calderon-Margalit R; Paltiel O; Manor O; Balicer RD; Greenfeld S; Kariv R; Ledderman N; Matz E; Peter I; Friedlander Y; Turner D
J Crohns Colitis; 2022 Sep; 16(9):1397-1404. PubMed ID: 35299254
[TBL] [Abstract][Full Text] [Related]
5. The Prevalence of Inflammatory Bowel Disease in Greenland.
Gantzel RH; Vesterdal JD; Haase AM; Petersen AJ; Grønbæk H; Pedersen ML
Inflamm Bowel Dis; 2023 Dec; 29(12):1879-1885. PubMed ID: 36702537
[TBL] [Abstract][Full Text] [Related]
6. The Association of Inflammatory Bowel Disease with Coeliac Disease and Coeliac Autoimmunity in Children and Adults: A Nationwide Study from the epi-IIRN.
Kori M; Zamir Y; Yermiyahu SO; Ainbinder I; Daichman S; Pinto GD; Loewenberg Weisband Y; Greenfeld S; Kariv R; Lederman N; Matz E; Shamir R; Dotan I; Turner D
J Crohns Colitis; 2023 May; 17(5):700-705. PubMed ID: 36394548
[TBL] [Abstract][Full Text] [Related]
7. The Association of Inflammatory Bowel Diseases with Autoimmune Disorders: A Report from the epi-IIRN.
Bar Yehuda S; Axlerod R; Toker O; Zigman N; Goren I; Mourad V; Lederman N; Cohen N; Matz E; Dushnitzky D; Gavish M; Borovsky N; Schwarts D; Dotan I; Turner D
J Crohns Colitis; 2019 Mar; 13(3):324-329. PubMed ID: 30304371
[TBL] [Abstract][Full Text] [Related]
8. Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study.
Jung YS; Han M; Kim WH; Park S; Cheon JH
Dig Dis Sci; 2017 Aug; 62(8):2102-2112. PubMed ID: 28593437
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory Bowel Disease in Appalachian Kentucky: An Investigation of Outcomes and Health Care Utilization.
Rhudy CN; Perry CL; Hawk GS; Flomenhoft DR; Talbert JC; Barrett TA
Inflamm Bowel Dis; 2024 Mar; 30(3):410-422. PubMed ID: 37280118
[TBL] [Abstract][Full Text] [Related]
10. Risk of Cancer in Paediatric onset Inflammatory Bowel Diseases: A Nation-wide Study From the epi-IIRN.
Atia O; Harel S; Ledderman N; Greenfeld S; Kariv R; Dotan I; Balicer R; Silverman B; Matz E; Levi Z; Waterman M; Fried I; Rowe JM; Turner D
J Crohns Colitis; 2022 Jun; 16(5):786-795. PubMed ID: 34791097
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
[TBL] [Abstract][Full Text] [Related]
12. Is Modern Medical Management Changing Ultimate Patient Outcomes in Inflammatory Bowel Disease?
Hatch QM; Ratnaparkhi R; Althans A; Keating M; Neupane R; Nishtala M; Johnson EK; Steele SR
J Gastrointest Surg; 2016 Nov; 20(11):1867-1873. PubMed ID: 27634305
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study.
Busingye D; Pollack A; Chidwick K
PLoS One; 2021; 16(5):e0252458. PubMed ID: 34043730
[TBL] [Abstract][Full Text] [Related]
14. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
[TBL] [Abstract][Full Text] [Related]
15. Lower regional and temporal ultraviolet exposure is associated with increased rates and severity of inflammatory bowel disease hospitalisation.
Limketkai BN; Bayless TM; Brant SR; Hutfless SM
Aliment Pharmacol Ther; 2014 Sep; 40(5):508-17. PubMed ID: 24943863
[TBL] [Abstract][Full Text] [Related]
16. Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study.
Murthy SK; Begum J; Benchimol EI; Bernstein CN; Kaplan GG; McCurdy JD; Singh H; Targownik L; Taljaard M
Gut; 2020 Feb; 69(2):274-282. PubMed ID: 31196874
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE-IBD registry.
Queiroz NSF; Martins CA; Quaresma AB; Hino AAF; Steinwurz F; Ungaro RC; Kotze PG
J Gastroenterol Hepatol; 2021 Nov; 36(11):3033-3040. PubMed ID: 34151470
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of Inflammatory Bowel Diseases in Israel: A Nationwide Epi-Israeli IBD Research Nucleus Study.
Stulman MY; Asayag N; Focht G; Brufman I; Cahan A; Ledderman N; Matz E; Chowers Y; Eliakim R; Ben-Horin S; Odes S; Dotan I; Balicer RD; Benchimol EI; Turner D
Inflamm Bowel Dis; 2021 Oct; 27(11):1784-1794. PubMed ID: 33438721
[TBL] [Abstract][Full Text] [Related]
19. Indicators of active disease and steroid dependency in patients with inflammatory bowel diseases not treated with biologics in a German real-world-setting.
Bokemeyer B; Ghiani M; Fuchs A; Deiters B; Hardtstock F; Brandes A; Knop J; Orzechowski HD; Wilke T
Int J Colorectal Dis; 2020 Aug; 35(8):1587-1598. PubMed ID: 32424526
[TBL] [Abstract][Full Text] [Related]
20. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
